UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dose escalation of biologics in Crohn's disease: critical review of observational studies

Current medical research and opinion, 2017-08, Vol.33 (8), p.1433-1449

2017

Volltextzugriff (PDF)

An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity

Journal of headache and pain, 2024-04, Vol.25 (1), p.59-59, Article 59

2024

Volltextzugriff (PDF)

Effect of Ganoderma lucidum on MPTP induced behavioral alterations in Swiss albino mice

Journal of young pharmacists, 2016-07, Vol.8 (3), p.194-197

2016

Volltextzugriff (PDF)

Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS)

Neurology and therapy, 2023-12, Vol.12 (6), p.2053-2065

2023

Volltextzugriff (PDF)

Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab

Journal of headache and pain, 2024-03, Vol.25 (1), p.45-45, Article 45

2024

Volltextzugriff (PDF)

Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration

Journal of comparative effectiveness research, 2023-07, Vol.12 (7), p.e230021-e230021

2023

Volltextzugriff (PDF)

The sharks and rays at Singapore’s fishery ports

Fisheries research, 2021-03, Vol.235, p.105805, Article 105805

2021

Volltextzugriff (PDF)

The impact of factor infusion frequency on health-related quality of life in people with haemophilia

Journal of Haemophilia Practice, 2020-08, Vol.7 (1), p.102-109

2020

Volltextzugriff (PDF)

Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention

Journal of medical economics, 2023-12, Vol.26 (1), p.1072-1080

2023

Volltextzugriff (PDF)

Concizumab Subcutaneous Prophylaxis Improves Health-Related Quality-of-Life Measures in Patients with Congenital Hemophilia with Inhibitors: Phase 2 Trial Results

Blood, 2019-11, Vol.134 (Supplement_1), p.2419-2419

2019

Volltextzugriff (PDF)

Long-term Maintenance of ≥50% Migraine Response with Eptinezumab Treatment in Patients with 2–4 Prior Preventive Migraine Treatment Failures (S22.008)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Shift in MHDs below the threshold of preventive optimization after eptinezumab treatment in patients with migraine and history of 2–4 preventive migraine treatment failures (P5-12.010)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: Post hoc analysis of the DELIVER trial (P13-12.012)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Estimation of the Impact on Treatment Costs of a Switch to Nonacog Beta Pegol (N9-GP) for the Treatment of Adults with Hemophilia B in Canada Based on Real-World Factor IX (FIX) Consumption and Clinical Outcomes Pre- and Post-Switch

Blood, 2020-11, Vol.136 (Supplement 1), p.19-19

2020

Volltextzugriff (PDF)

Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment (P7-12.004)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

The management of type 2 diabetes with fixed‐ratio combination insulin degludec/liraglutide (IDegLira) versus basal‐bolus therapy (insulin glargine U100 plus insulin aspart): A short‐term cost‐effectiveness analysis in the UK setting

Diabetes, obesity & metabolism, 2018-10, Vol.20 (10), p.2371-2378

2018

Volltextzugriff (PDF)

Patient-identified most bothersome symptom as a driver of health-related quality of life experienced by patients with migraine (P8-12.010)

Neurology, 2023, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Effect of Eptinezumab on Utility Scores in Patients with Migraine: Results from the DELIVER Study (P13-12.011)

Neurology, 2023, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment

Headache, 2023-04, Vol.63 (4), p.484-493

2023

Volltextzugriff (PDF)

Novel Nanostructured Lipid Carriers with Photoprotective Properties Made from Carnauba Wax, Beeswax, and Kenaf Seed Oil

Journal of the American Oil Chemists' Society, 2019-02, Vol.96 (2), p.201-211

2019

Volltextzugriff (PDF)

CO 2 adsorption of MSU-2 synthesized by using nonionic polyethyleneoxide (PEO)-based surfactants

Chemical engineering communications, 2021-04, Vol.208 (4), p.474-482

2021

Volltextzugriff (PDF)

Real-world utilities and health-related quality-of-life data in hemophilia patients in France and the United Kingdom

Patient preference and adherence, 2019-06, Vol.13, p.941-957

2019

Volltextzugriff (PDF)

CO2 adsorption of MSU-2 synthesized by using nonionic polyethyleneoxide (PEO)-based surfactants

Chemical engineering communications, 2021-03, Vol.208 (4), p.474-482

2021

Volltextzugriff (PDF)

Long-Term Outcomes of Previously Treated Adult and Adolescent Patients with Severe Hemophilia A Receiving Prophylaxis with Extended Half-Life FVIII Treatments: An Economic Analysis from a United Kingdom Perspective

ClinicoEconomics and outcomes research, 2021-01, Vol.13, p.39-51

2021

Volltextzugriff (PDF)

Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients

Diabetes therapy, 2018-10, Vol.9 (5), p.1931-1944

2018

Volltextzugriff (PDF)

1 – 25 von 479

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(410)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(303)
Life Sciences & Biomedicine
(164)
Humans
(108)
Technology
(81)
Physical Sciences
(72)
Science & Technology - Other Topics
(53)
Animals
(47)
Chemistry
(42)
Multidisciplinary Sciences
(37)
Materials Science
(36)
Mice
(36)
Engineering
(33)
Male
(32)
Biochemistry & Molecular Biology
(26)
Female
(26)
Science
(26)
Humanities And Social Sciences
(25)
Multidisciplinary
(25)
Cell Line, Tumor
(24)
Gene Expression
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Dose escalation of biologics in Crohn's disease: critical review of observational studies

An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity

Effect of Ganoderma lucidum on MPTP induced behavioral alterations in Swiss albino mice

Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS)

Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab

Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration

The sharks and rays at Singapore’s fishery ports

The impact of factor infusion frequency on health-related quality of life in people with haemophilia

Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention

Concizumab Subcutaneous Prophylaxis Improves Health-Related Quality-of-Life Measures in Patients with Congenital Hemophilia with Inhibitors: Phase 2 Trial Results

Long-term Maintenance of ≥50% Migraine Response with Eptinezumab Treatment in Patients with 2–4 Prior Preventive Migraine Treatment Failures (S22.008)

Shift in MHDs below the threshold of preventive optimization after eptinezumab treatment in patients with migraine and history of 2–4 preventive migraine treatment failures (P5-12.010)

Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: Post hoc analysis of the DELIVER trial (P13-12.012)

Estimation of the Impact on Treatment Costs of a Switch to Nonacog Beta Pegol (N9-GP) for the Treatment of Adults with Hemophilia B in Canada Based on Real-World Factor IX (FIX) Consumption and Clinical Outcomes Pre- and Post-Switch

Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment (P7-12.004)

The management of type 2 diabetes with fixed‐ratio combination insulin degludec/liraglutide (IDegLira) versus basal‐bolus therapy (insulin glargine U100 plus insulin aspart): A short‐term cost‐effectiveness analysis in the UK setting

Patient-identified most bothersome symptom as a driver of health-related quality of life experienced by patients with migraine (P8-12.010)

Effect of Eptinezumab on Utility Scores in Patients with Migraine: Results from the DELIVER Study (P13-12.011)

Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment

Novel Nanostructured Lipid Carriers with Photoprotective Properties Made from Carnauba Wax, Beeswax, and Kenaf Seed Oil

CO 2 adsorption of MSU-2 synthesized by using nonionic polyethyleneoxide (PEO)-based surfactants

Real-world utilities and health-related quality-of-life data in hemophilia patients in France and the United Kingdom

CO2 adsorption of MSU-2 synthesized by using nonionic polyethyleneoxide (PEO)-based surfactants

Long-Term Outcomes of Previously Treated Adult and Adolescent Patients with Severe Hemophilia A Receiving Prophylaxis with Extended Half-Life FVIII Treatments: An Economic Analysis from a United Kingdom Perspective

Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients

Aktive Filter

Suchergebnisse filtern